These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 27782369
1. The structure of brain glycogen phosphorylase-from allosteric regulation mechanisms to clinical perspectives. Mathieu C, Dupret JM, Rodrigues Lima F. FEBS J; 2017 Feb; 284(4):546-554. PubMed ID: 27782369 [Abstract] [Full Text] [Related]
2. Insights into Brain Glycogen Metabolism: THE STRUCTURE OF HUMAN BRAIN GLYCOGEN PHOSPHORYLASE. Mathieu C, Li de la Sierra-Gallay I, Duval R, Xu X, Cocaign A, Léger T, Woffendin G, Camadro JM, Etchebest C, Haouz A, Dupret JM, Rodrigues-Lima F. J Biol Chem; 2016 Aug 26; 291(35):18072-83. PubMed ID: 27402852 [Abstract] [Full Text] [Related]
3. The Structure and the Regulation of Glycogen Phosphorylases in Brain. Mathieu C, Dupret JM, Rodrigues-Lima F. Adv Neurobiol; 2019 Aug 26; 23():125-145. PubMed ID: 31667807 [Abstract] [Full Text] [Related]
4. An Isozyme-specific Redox Switch in Human Brain Glycogen Phosphorylase Modulates Its Allosteric Activation by AMP. Mathieu C, Duval R, Cocaign A, Petit E, Bui LC, Haddad I, Vinh J, Etchebest C, Dupret JM, Rodrigues-Lima F. J Biol Chem; 2016 Nov 11; 291(46):23842-23853. PubMed ID: 27660393 [Abstract] [Full Text] [Related]
6. Glycogen phosphorylase revisited: extending the resolution of the R- and T-state structures of the free enzyme and in complex with allosteric activators. Leonidas DD, Zographos SE, Tsitsanou KE, Skamnaki VT, Stravodimos G, Kyriakis E. Acta Crystallogr F Struct Biol Commun; 2021 Sep 01; 77(Pt 9):303-311. PubMed ID: 34473107 [Abstract] [Full Text] [Related]
7. Probing the catalytic site of rabbit muscle glycogen phosphorylase using a series of specifically modified maltohexaose derivatives. Nakamura M, Makino Y, Takagi C, Yamagaki T, Sato M. Glycoconj J; 2017 Aug 01; 34(4):563-574. PubMed ID: 28597243 [Abstract] [Full Text] [Related]
9. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol. Tsitsanou KE, Hayes JM, Keramioti M, Mamais M, Oikonomakos NG, Kato A, Leonidas DD, Zographos SE. Food Chem Toxicol; 2013 Nov 25; 61():14-27. PubMed ID: 23279842 [Abstract] [Full Text] [Related]
10. Chemoproteomic fishing identifies arzanol as a positive modulator of brain glycogen phosphorylase. Del Gaudio F, Pollastro F, Mozzicafreddo M, Riccio R, Minassi A, Monti MC. Chem Commun (Camb); 2018 Nov 13; 54(91):12863-12866. PubMed ID: 30375590 [Abstract] [Full Text] [Related]
11. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site. Kristiansen M, Andersen B, Iversen LF, Westergaard N. J Med Chem; 2004 Jul 01; 47(14):3537-45. PubMed ID: 15214781 [Abstract] [Full Text] [Related]
12. The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor. Zographos SE, Oikonomakos NG, Tsitsanou KE, Leonidas DD, Chrysina ED, Skamnaki VT, Bischoff H, Goldmann S, Watson KA, Johnson LN. Structure; 1997 Nov 15; 5(11):1413-25. PubMed ID: 9384557 [Abstract] [Full Text] [Related]
13. Modeling aided design of potent glycogen phosphorylase inhibitors. Deng Q, Lu Z, Bohn J, Ellsworth KP, Myers RW, Geissler WM, Harris G, Willoughby CA, Chapman K, McKeever B, Mosley R. J Mol Graph Model; 2005 Apr 15; 23(5):457-64. PubMed ID: 15781188 [Abstract] [Full Text] [Related]
14. Glycogen phosphorylase as a molecular target for type 2 diabetes therapy. Oikonomakos NG. Curr Protein Pept Sci; 2002 Dec 15; 3(6):561-86. PubMed ID: 12470212 [Abstract] [Full Text] [Related]
15. Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors. Anderka O, Loenze P, Klabunde T, Dreyer MK, Defossa E, Wendt KU, Schmoll D. Biochemistry; 2008 Apr 22; 47(16):4683-91. PubMed ID: 18373353 [Abstract] [Full Text] [Related]
16. Glycogen debranching enzyme in bovine brain. Narahara E, Makino Y, Omichi K. J Biochem; 2001 Sep 22; 130(3):465-70. PubMed ID: 11530024 [Abstract] [Full Text] [Related]
17. Chimeric muscle and brain glycogen phosphorylases define protein domains governing isozyme-specific responses to allosteric activation. Crerar MM, Karlsson O, Fletterick RJ, Hwang PK. J Biol Chem; 1995 Jun 09; 270(23):13748-56. PubMed ID: 7775430 [Abstract] [Full Text] [Related]
18. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies. Wen X, Sun H, Liu J, Cheng K, Zhang P, Zhang L, Hao J, Zhang L, Ni P, Zographos SE, Leonidas DD, Alexacou KM, Gimisis T, Hayes JM, Oikonomakos NG. J Med Chem; 2008 Jun 26; 51(12):3540-54. PubMed ID: 18517260 [Abstract] [Full Text] [Related]
19. A dimeric catalytic core relates the short and long forms of ATP-phosphoribosyltransferase. Mittelstädt G, Jiao W, Livingstone EK, Moggré GJ, Nazmi AR, Parker EJ. Biochem J; 2018 Jan 05; 475(1):247-260. PubMed ID: 29208762 [Abstract] [Full Text] [Related]
20. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase. Kaiser A, Nishi K, Gorin FA, Walsh DA, Bradbury EM, Schnier JB. Arch Biochem Biophys; 2001 Feb 15; 386(2):179-87. PubMed ID: 11368340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]